Quantification of Remimazolam Besylate (CNS7056B) and Its Metabolite (CNS7054X) by LC–MS/MS in Human Plasma Using Midazolam-d4 Maleate as Internal Standard

Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers

(2020) Jürgen Schüttler et al.   ANESTHESIOLOGY

Remimazolam for anaesthesia or sedation

(2020) J. Robert Sneyd et al.   Current Opinion in Anesthesiology

Recommendations and best practices for calibration curves in quantitative LC–MS bioanalysis

(2019) Yunlin Fu et al.   Bioanalysis

Simultaneous determination of remimazolam and its carboxylic acid metabolite in human plasma using ultra-performance liquid chromatography–tandem mass spectrometry

(2015) Ying Zhou et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)

(2012) Hugh R. Wiltshire et al.   ANESTHESIA AND ANALGESIA

Analysis of total and unbound hydromorphone in human plasma by ultrafiltration and LC–MS/MS: Application to clinical trial in patients undergoing open heart surgery

(2012) Teijo I. Saari et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)

(2011) Laurie J. Antonik et al.   ANESTHESIA AND ANALGESIA